Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Nivolumab + Standard Treatment for Stomach and Esophageal Cancer
Recruiting1 awardPhase 2 & 3
Glens Falls, New York
This trial is testing if adding nivolumab, a type of immunotherapy drug, to the standard treatment of paclitaxel and ramucirumab is more effective in treating patients
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service